Article | January 9, 2019

5 Must-Dos To Build Trust Between An Early-Stage Biotech And CRO

Source: Premier Research

Most early-stage biotechnology companies have limited resources and manpower. As a result, early-stage biotechs conducting randomized clinical trial research often need a CRO’s help to deliver the quality data required to make their ideas and theories achieve practical purpose. In addition, engaging a CRO with a depth of strategic expertise early in the planning process can provide sponsors with additional knowledge when building out an effective operational program.

Building a partnership of trust between the biotech’s internal team and its CRO of choice is essential. Here are five places to begin: